evidence based pediatric oncology 2 edition
Evidence-Based Pediatric Oncology, 2 edition
$202.00 Original price was: $202.00.$4.99Current price is: $4.99. Add to cart
Sale!

Evidence-Based Pediatric Oncology, 2 edition

Original price was: $202.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Mathematical Cure: Evidence-Based Pediatric Oncology

Treating a child with cancer is not an art; it is a rigid mathematical science. Over 80% of children with cancer are cured today not because of a single miracle drug, but because of decades of massive, multi-national, meticulously structured clinical trials. Evidence-Based Pediatric Oncology, 2nd edition is a brutally objective, strictly data-driven manual detailing exactly how these statistical victories were achieved. This volume provides the absolute blueprints for practicing the highest standard of pediatric cancer care.

Mastering the Trial Protocol

The core philosophy of this text is strict adherence to the proven algorithm. The authors aggressively detail the results of the Children’s Oncology Group (COG) trials. It dictates exactly why a child with standard-risk Acute Lymphoblastic Leukemia (ALL) receives precisely four specific drugs (vincristine, a steroid, pegaspargase, and intrathecal chemo) during induction, proving mathematically that deviating from this exact recipe significantly lowers the child’s chance of survival.

Navigating Late Effects

The book provides a masterclass in the cost of the cure. It dictates the exact clinical pathways for long-term survivorship. It rigorously explores the devastating reality that curing a 5-year-old with radiation and anthracyclines means they are at massive statistical risk for developing radiation-induced secondary cancers or catastrophic heart failure in their 30s, demanding highly structured, lifelong medical surveillance.

Frequently Asked Questions (FAQs)

Is this a book about experimental therapies for incurable patients?
No, it is a strictly *evidence-based clinical manual* focused entirely on the established, mathematically proven standard of care used to cure the vast majority of pediatric patients.

Who is the primary audience?
It is the absolute, mandatory definitive reference for Pediatric Oncologists, Pediatric Hematologists, and Oncology Nurses.